Open AccessLobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk
Author(s) -
Tari A. King,
Melissa Pilewskie,
Shirin Muhsen,
Sujata Patil,
Starr Koslow Mautner,
Anna Park,
Sabine Oskar,
Elena GueriniRocco,
Camilla Boafo,
Jessica C. Gooch,
Marina De Brot,
Jorge S. ReisFilho,
Mary Morrogh,
Victor Piana de Andrade,
Rita A. Sakr
Publication year - 2015
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2015.61.4743
Subject(s) - medicine , lobular carcinoma , breast cancer , ductal carcinoma , hazard ratio , cumulative incidence , oncology , cancer , mastectomy , carcinoma in situ , incidence (geometry) , cancer registry , gynecology , confidence interval , cohort , physics , optics
The increased breast cancer risk conferred by a diagnosis of lobular carcinoma in situ (LCIS) is poorly understood. Here, we review our 29-year longitudinal experience with LCIS to evaluate factors associated with breast cancer risk.